FGF13 and epilepsy: FHF2 mutations have been identified in individuals with epilepsy where the change to the FHF protein results in a reduction in LTI, likely causing gain of function effects on overall circuit excitability, leading to infantile onset of developmental delay and intractable focal seizures [27].